About Us
From the beginning, the founders envisioned a company that consistently improve and replace the current molecular diagnostic methods by new biotechnology to combat challenging diseases.
Medix Biochemica founded in Finland
Multienzyme Isothermal Rapid Amplification Technology Development Stage.
2008
Medix Biochemica China established
Weifang Amp-future Biotech Co., Ltd was the first established biotech enterprise in the biotechnology park of Weifang including a number of biomolecular diagnosis technology with independent intellectual property rights.
2019
Medix Biochemica USA established
Amp-Future(Changzhou) Biotech Co., Ltd was established with larger production capacity and the belief of becoming the professional supplier of Molecular Diagnostic Solutions worldwide.
2020
Lee Biosolutions acquired
Amp-future(Changzhou) developed COVID-19 solutions with high detection sensitivity and rapid result based on MIRA and supplied to many biotechnology companies.
2020
EastCoast Bio and Biostride acquired
Weifang Amp-future was issued for “High and New Tech Enterprise” by government.
2021
MedixMDx established and Diaclone acquired
Amp-future(Changzhou) gained b round of investing.This is not the end…
2022
From the beginning, the founders envisioned a company that consistently improve and replace the current molecular diagnostic methods by new biotechnology to combat challenging diseases.
2008 Multienzyme Isothermal Rapid Amplification Technology Development Stage.
2019 Weifang Amp-future Biotech Co., Ltd was the first established biotech enterprise in the biotechnology park of Weifang including a number of biomolecular diagnosis technology with independent intellectual property rights.
2020 Amp-Future(Changzhou) Biotech Co., Ltd was established with larger production capacity and the belief of becoming the professional supplier of Molecular Diagnostic Solutions worldwide.
2020 Amp-future(Changzhou) developed COVID-19 solutions with high detection sensitivity and rapid result based on MIRA and supplied to many biotechnology companies.
2021 Weifang Amp-future was issued for “High and New Tech Enterprise” by government.
2022 Amp-future(Changzhou) gained b round of investing.
This is not the end…
